Outset Medical Inc. (OM)
NASDAQ (NGS) NASDAQ (NGS) Primary 
Outset Medical (OM) Soars 22.2%: Is Further Upside Left in the Stock?
Outset Medical (OM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Outset Medical, Inc. (OM) Reports Q3 Loss, Lags Revenue Estimates
Outset Medical, Inc. (OM) came out with a quarterly loss of $0.69 per share versus the Zacks Consensus Estimate of a loss of $0.64. This compares to a loss of $5.85 per share a year ago.
Outset Medical, Inc. (OM) Q3 2025 Earnings Call Transcript
Outset Medical, Inc. ( OM ) Q3 2025 Earnings Call November 10, 2025 4:30 PM EST Company Participants James Mazzola - Vice President of Corporate Communications & Investor Relations Leslie Trigg - President, CEO & Chairman Renee Gaeta - CFO, Principal Financial Officer & Principal Accounting Officer Conference Call Participants Frederick Wise - Stifel, Nicolaus & Company, Incorporated, Research Division Shagun Singh Chadha - RBC Capital Markets, Research Division Marie Thibault - BTIG, LLC, Research Division Joshua Jennings - TD Cowen, Research Division Presentation Operator Good day, and thank you for standing by. Welcome to the Outset Medical Q3 2025 Earnings Conference Call.
Outset Medical, Inc. (OM) Q2 2025 Earnings Call Transcript
Outset Medical, Inc. (NASDAQ:OM ) Q2 2025 Earnings Conference Call August 6, 2025 5:00 PM ET Company Participants James S. Mazzola - Head of Investor Relations Leslie L.
Outset Medical, Inc. (OM) Reports Q2 Loss, Beats Revenue Estimates
Outset Medical, Inc. (OM) came out with a quarterly loss of $0.84 per share versus the Zacks Consensus Estimate of a loss of $1.76. This compares to a loss of $7.05 per share a year ago.
Why Outset Medical's Rock-Bottom Valuation Masks Explosive Growth
The company's business model leverages recurring revenue streams and strong customer retention, supporting stable long-term growth. Key risks include potential regulatory changes and execution challenges that could impact future earnings. With FDA hurdles behind it and sales momentum building, Outset's Tablo is regaining traction across hospitals and ICU settings.
Strength Seen in Outset Medical (OM): Can Its 15.0% Jump Turn into More Strength?
Outset Medical (OM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Outset Medical, Inc. (OM) Reports Q1 Loss, Tops Revenue Estimates
Outset Medical, Inc. (OM) came out with a quarterly loss of $3.24 per share versus the Zacks Consensus Estimate of a loss of $0.97. This compares to loss of $8.55 per share a year ago.
Does Outset Medical (OM) Have the Potential to Rally 71.66% as Wall Street Analysts Expect?
The consensus price target hints at a 71.7% upside potential for Outset Medical (OM). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Wall Street Analysts Predict an 188.63% Upside in Outset Medical (OM): Here's What You Should Know
The consensus price target hints at an 188.6% upside potential for Outset Medical (OM). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Bears are Losing Control Over Outset Medical (OM), Here's Why It's a 'Buy' Now
Outset Medical (OM) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
3 Cryptocurrencies That Could Be Better Buys Than Bitcoin Right Now
In 2025, Bitcoin (BTC -1.18%) has over-promised and under-delivered. After reaching $100,000 in December, Bitcoin looked like a no-brainer option to soar in value this year.
